| dc.contributor.author | Nattress, CB | en_US |
| dc.contributor.author | Hallden, G | en_US |
| dc.date.accessioned | 2020-08-24T15:13:58Z | |
| dc.date.available | 2018-07-03 | en_US |
| dc.date.issued | 2018 | en_US |
| dc.identifier.issn | 0304-3835 | en_US |
| dc.identifier.uri | https://qmro.qmul.ac.uk/xmlui/handle/123456789/66584 | |
| dc.format.extent | 56 - 69 | en_US |
| dc.language.iso | en | en_US |
| dc.relation.ispartof | CANCER LETTERS | en_US |
| dc.rights | © 2018. This manuscript version is made available under the CC-BY-NC-ND 4.0 license http://creativecommons.org/licenses/by-nc-nd/4.0/ | |
| dc.subject | Oncolytic virus | en_US |
| dc.subject | Pancreatic cancer | en_US |
| dc.subject | Adenovirus | en_US |
| dc.subject | Clinical trials | en_US |
| dc.subject | PDAC | en_US |
| dc.title | Advances in oncolytic adenovirus therapy for pancreatic cancer | en_US |
| dc.type | Article | |
| dc.identifier.doi | 10.1016/j.canlet.2018.07.006 | en_US |
| pubs.author-url | http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000444666500006&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6a | en_US |
| pubs.notes | Not known | en_US |
| pubs.publication-status | Published | en_US |
| pubs.volume | 434 | en_US |
| rioxxterms.funder | Default funder | en_US |
| rioxxterms.identifier.project | Default project | en_US |
